Dominick A. Conde

Partner
Dom Conde

Dom Conde is co-chair of Venable's Intellectual Property Division. Dom is a noted patent litigator who represents pharmaceutical companies in large-scale patent litigation – often involving high-value ANDA matters. He serves as lead counsel in Hatch-Waxman litigation, and regularly represents clients in contested proceedings before the U.S. Patent and Trademark Office. In addition to pharmaceutical clients, Dom represents clients in a variety of other industries, including biotechnology, chemicals, consumer goods, energy, industrial equipment and manufacturing, and medical devices. Before joining Venable, Dom was chair at Fitzpatrick, Cella, Harper & Scinto.

Experience

Representative Matters

  • Representing Astellas against Cipla, Annora, Xuanmu Hangzhou, and Apotex on patents covering Cresemba® used to treat fungal infections
  • Representing Jazz and Pharma Mar against InvaGen, RK Pharma, Dr. Reddy’s, Zydus, MSN, and Sandoz on patents covering the small cell lung cancer drug Zepzelca®
  • Representing Melinta Therapeutics against Nexus and Gland on patent covering Minocin® used to treat bacterial infections
  • Representing Vedanta in a patent litigation regarding Nestlé’s sales of its product Vowst® used to prevent the recurrence of Clostridioides difficile infection (CDI) following antibacterial treatment for recurrent CDI (rCDI)
  • Represented Currax against Taro, Ajanta, Mylan, and MSN relating to Silenor® used as a sleep aid
  • Represented Astellas, Pfizer, and the University of California in litigation against Actavis, Apotex, Aurobindo, Hikma, Zydus, Sandoz, Sun, Humanwell PuraCap, Qilu, SinoTherapeutics, Ascent, Lupin, and Hetero on patents covering the prostate cancer drug Xtandi®
  • Represented Aralez Pharmaceuticals against Actavis on patents covering Yosprala®, used for the prevention of cardiovascular events for patients that are at risk of developing gastric ulcers
  • Represented Pernix Therapeutics against Alvogen and Actavis on patents covering Zohydro®, used to relief severe pain 
  • Represented Sanofi-Aventis against Fresenius, Accord Healthcare, Mylan, and Actavis on patents covering Jevtana®, used to treat metastatic prostate cancer  
  • Represented Pozen Inc. against Actavis, Dr. Reddy’s Laboratories, Mylan, and Lupin on patents covering Vimovo®, used by patients who have arthritis pain and risk of NSAID-induced stomach ulcers
  • Represented Warner Chilcott against Lupin and Watson Laboratories on patents covering Lo Loestrin 24®, a low-dose oral contraceptive
  • Represented Warner Chilcott against Watson Laboratories on a patent covering Loestrin 24®, an oral contraceptive 
  • Represented Reliable Sprinkler Co. against a complaint filed by Tyco Fire Products on multiple patents related to fire protection sprinklers
  • Represented Sanofi-Aventis against Sandoz Inc., et al. on a patent related to Eloxatin®, a treatment option for stage III colon cancer and advanced colorectal cancer
  • Represented Warner Chilcott against multiple defendants on a patent related to Doryx®, a broad-spectrum tetracycline antibiotic
  • Represented Warner Chilcott against Barr Laboratories and Watson Pharmaceuticals on patents related to Warner Chilcott’s Femcon Fe®, a chewable oral contraceptive
  • Represented Entegris against infringement allegations related to filtration technology
  • Represented Reckitt Benckiser against Tris Pharmaceuticals and Amneal Pharmaceuticals on patents related to Delsum®, a 12-hour cough suppressant
  • Represented Sepracor Pharmaceuticals against Sandoz Inc., et al. on patents related to Clarinex®, an allergy medication
  • Represented Adams Respiratory against multiple defendants on patents related to Adams’ highly successful Mucinex® product
  • Represented KOS Pharmaceuticals against Barr Laboratories on patents covering KOS’s niaspan anticholesterol drugs
  • Represented Bristol Myers against Teva Pharmaceuticals regarding patents covering Bristol’s antibacterial agent gatifloxacin
  • Represented Warner Chilcott against KV Pharmaceuticals on a patent covering pregnancy vitamins
  • Represented Bristol-Myers against Rhône-Poulenc Rorer on patents related to a semi-synthetic process technology for making Taxol
  • Represented Dixon Ticonderoga against Dri Mark Products in patents involving metallic inks used in writing instruments
  • Represented American Maize Products against Grain Processing Corp. on patents related to maltodextrin food additives
  • Represented Bausch & Lomb against Alcon Laboratories regarding technology for contact lens disinfectants
  • Represented Exxon against Lubrizol regarding motor oil additives

Representative Clients

  • Astellas Pharma
  • Jazz Pharmaceuticals
  • Melinta Therapeutics
  • Currax Pharmaceuticals

Insights

Credentials
+

Education

  • J.D. Franklin Pierce Law Center 1990
  • B.S. Mechanical Engineering Rensselaer Polytechnic Institute 1982

Bar Admissions

  • New York 1991
  • U.S. Patent and Trademark Office

Court Admissions

  • U.S. Court of Appeals for the Federal Circuit
  • U.S. District Court for the Southern District of New York
  • U.S. District Court for the Eastern District of New York
  • U.S. District Court for the Western District of New York
  • U.S. Supreme Court

Recognition
+

Dom is known not only as an "intellectual giant" (Best Lawyers), but as a "mature, pragmatic lawyer with great judgment" (IAM 250). Chambers USA writes that Dom "completely stands out, in terms of raw intelligence, lawyering skills and putting together the perfect case."

  • The Best Lawyers in America, 2024
    • Lawyer of the Year, Patent Law, 2023
    • Intellectual Property, 2011, 2014 – 2022
    • Litigation, Intellectual Property, 2023, 2025
    • Patent Law, 2025
  • Who's Who Legal, Patents, 2020
  • LMG Life Sciences
    • Life Sciences Star, 2019 - 2020, 2022
    • Leading Lawyer, 2012 – 2018
  • New York Law Journal, Burton Award for Legal Achievement, 2015
  • Managing Intellectual Property
    • IP Star, 2013 – 2020, 2022 – 2025
    • Top 10 Life Science Litigator, 2013 – 2015
  • IAM Patent 1000, The World's Leading Patent Practitioners, 2012 – 2019, 2021 – 2025
  • IAM, Global Leaders, 2022, 2025 – 2026
  • Chambers USA, Intellectual Property: Patent, New York, 2011 – 2025
  • Legal 500, Intellectual Property - Patents: Litigation (full coverage), 2008, 2009, 2011, 2012, 2014 – 2025
  • Super Lawyers, Intellectual Property Litigation, New York Metro, 2006 – 2010, 2012 – 2023